
Sri Krishna Health Care And Pharmaceuticals Private Limited
Hospitality and healthcare services since 1994, based in Tamil Nadu.
Hospitality and healthcare services since 1994, based in Tamil Nadu.
Sri Krishna Health Care And Pharmaceuticals Private Limited (SKHCAPPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 27 September 1994 and has a history of 30 years and five months. Its registered office is in Cuddalore, Tamil Nadu, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 3.00 M and a paid-up capital of Rs 2.69 M.
The company currently has active open charges totaling ₹4.00 Cr.
Kothandapani Kothandapani, Lakshmi Krishnamurthy, Srikrishna, and One other member serve as directors at the Company.
Cuddalore, Tamil Nadu, India
+91-XXXXXXXXXX
-
U85110TN1994PTC028741
028741
Private Limited Indian Non-Government Company
27 Sep 1994
30 Sep 2023
31 Mar 2023
Unlisted
Roc Chennai
Name | Designation | Appointment Date | Status |
---|---|---|---|
Lakshmi Krishnamurthy ![]() | Managing Director | 27-Sep-1994 | Current |
Name | Designation | Appointment Date | Status |
---|---|---|---|
Kothandapani Kothandapani ![]() | Director | 27-Sep-1994 | Current |
Srikrishna ![]() | Director | 30-Sep-2004 | Current |
Ramya Korrapatti ![]() | Director | 16-Dec-2013 | Current |
Sri Krishna Health Care And Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 18.24% decrease. The company also saw a substantial fall in profitability, with a 52.57% decrease in profit. The company's net worth moved up by a moderate rise of 5.52%.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
In 2023, Sri Krishna Health Care And Pharmaceuticals had a public holding of 39.76%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Srikrishna is a mutual person
₹40.00 M
₹0
Date | Lender | Amount | Status |
---|---|---|---|
30 Jun 2015 | City Union Bank Limited | ₹4.00 Cr | Open |
Sri Krishna Health Care And Pharmaceuticals has a workforce of 12 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Sri Krishna Health Care And Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sri Krishna Health Care And Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Sri Krishna Health Care And Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.
Sri Krishna Health Care And Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Chennai.
A charge with City Union Bank Limited of Rs. 40.00 M registered on 30 Jun 2015 with Charge ID 10589191 was modified on 28 Oct 2017.
A charge with City Union Bank Limited amounted to Rs. 40.00 M with Charge ID 10589191 was registered on 30 Jun 2015.
Ramya Korrapatti was appointed as a Director was appointed as a Director on 16 Dec 2013 & has been associated with this company since 11 years 2 months .
Srikrishna was appointed as a Director was appointed as a Director on 30 Sep 2004 & has been associated with this company since 20 years 5 months .
Sri Krishna Health Care And Pharmaceuticals Private Limited was incorporated on 27 Sep 1994.
The authorized share capital of Sri Krishna Health Care And Pharmaceuticals Private Limited is ₹ 3.00 M and paid-up capital is ₹ 2.69 M.
Currently 4 directors are associated with Sri Krishna Health Care And Pharmaceuticals Private Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Sri Krishna Health Care And Pharmaceuticals Private Limited is 17 - A, Hospital Road India, Cuddalore-607001, Tamil Nadu.
The corporate identification number (CIN) of Sri Krishna Health Care And Pharmaceuticals Private Limited is U85110TN1994PTC028741 and the company number is 028741 as per Ministry of Corporate Affairs (MCA).
According to the financial reports for the fiscal year 2023, the revenue trend for Sri Krishna Health Care And Pharmaceuticals Private Limited has fallen by -18.24%.
As Per 2023 financial reports, 12 employees are currently employed by Sri Krishna Health Care And Pharmaceuticals Private Limited.
The financial reports for the fiscal year 2023 indicates that The net worth of Sri Krishna Health Care And Pharmaceuticals Private Limited has experienced an upsurge of 5.52%.
As per the financial statements for fiscal Year 2023, The total open charges for Sri Krishna Health Care And Pharmaceuticals Private Limited amount to ₹ 4.00 Cr.
The most recent Balance Sheet for Sri Krishna Health Care And Pharmaceuticals Private Limited was filed with the ROC on 31 Mar 2023.